Anastrozole cuts breast cancer cases by more than 50% in high risk women

Cancer cells and the immune system: a natural story?

Immuno-Oncology: the next new paradigm in cancer treatment? Chairman's welcome and introduction

Immuno-Oncology: a concept or already a reality?

Why are Immuno-Oncology compounds different?

The role of molecular pathways in therapeutic response and outcomes in breast cancer

Traditional and personalised models of therapy in gastrointestinal and endocrine tumours: the role of histological and clinical markers

Future perspectives: realising the potential of personalised healthcare in gynaecological cancer

Role of metronomics in cancer clinical trials and practice in developing countries

Integrating breast cancer genomics and proteomics

Next wave of successful drug therapy strategies in HER2-positive breast cancer

Genetic and clinical factors best for predicting late recurrence in oestrogen receptor positive breast cancer